Skip to Content

Astepro Approval History

FDA Approved: Yes (First approved October 15, 2008)
Brand name: Astepro
Generic name: azelastine
Dosage form: Nasal Spray
Company: Meda AB
Treatment for: Allergic Rhinitis

Astepro (azelastine) is a nasal antihistamine for the treatment of seasonal allergic rhinitis.

Development History and FDA Approval Process for Astepro

DateArticle
Sep  2, 2009Approval Meda Receives FDA Approval of New Astepro (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
Oct 17, 2008Approval FDA Approves Astepro

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide